Linda Nocchi's Colleagues at Nouscom AG
Biljana Petrovic
Development of personalized antitumor vaccine. Engineering
Linda Nocchi's Contact Details
+41 61 201 18 31
Pomezia,Lazio,00071,Italy
Nouscom AG
Linda Nocchi's Company Details
Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators. Nouscom is led by an experienced management team that has worked together for many years in previous successful enterprises, including IRBM/Merck and Okairos (acquired by GSK), and are veterans in the field of genetic vaccines. Nouscom, which was founded in 2015 and is headquartered in Basel, Switzerland with operations in Rome, Italy, is backed by international life sciences investors: 5AM, Abingworth, LSP (Life Sciences Partners) and Versant Ventures. For more information on Nouscom, please visit the company's website at www.nouscom.com